Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Fosravuconazole by Eisai for Tinea Pedis (Athlete Foot): Likelihood of Approval
Fosravuconazole is under clinical development by Eisai and currently in Phase II for Tinea Pedis (Athlete Foot). According to GlobalData,...
Fosravuconazole by Eisai for Fungal Infections: Likelihood of Approval
Fosravuconazole is under clinical development by Eisai and currently in Phase III for Fungal Infections. According to GlobalData, Phase III...
Fosravuconazole by Eisai for Tinea Pedis (Athlete Foot): Likelihood of Approval
Fosravuconazole is under clinical development by Eisai and currently in Phase II for Tinea Pedis (Athlete Foot). According to GlobalData,...